These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

856 related articles for article (PubMed ID: 33568459)

  • 1. Uncovering the Hidden Credentials of
    Roop RM; Barton IS; Hopersberger D; Martin DW
    Microbiol Mol Biol Rev; 2021 Feb; 85(1):. PubMed ID: 33568459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host.
    Roop RM; Gaines JM; Anderson ES; Caswell CC; Martin DW
    Med Microbiol Immunol; 2009 Nov; 198(4):221-38. PubMed ID: 19830453
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Giménez A; Del Giudice MG; López PV; Guaimas F; Sámano-Sánchez H; Gibson TJ; Chemes LB; Arregui CO; Ugalde JE; Czibener C
    mBio; 2024 Jul; 15(7):e0072624. PubMed ID: 38847540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brucella - Virulence Factors, Pathogenesis and Treatment.
    Głowacka P; Żakowska D; Naylor K; Niemcewicz M; Bielawska-Drózd A
    Pol J Microbiol; 2018 Jun; 67(2):151-161. PubMed ID: 30015453
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Li P; Tian M; Bao Y; Hu H; Liu J; Yin Y; Ding C; Wang S; Yu S
    Front Cell Infect Microbiol; 2017; 7():422. PubMed ID: 29021973
    [No Abstract]   [Full Text] [Related]  

  • 6. Internal affairs: investigating the Brucella intracellular lifestyle.
    von Bargen K; Gorvel JP; Salcedo SP
    FEMS Microbiol Rev; 2012 May; 36(3):533-62. PubMed ID: 22373010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of Chronic Infection: Brucella's Stealth Strategy.
    Ahmed W; Zheng K; Liu ZF
    Front Cell Infect Microbiol; 2016; 6():30. PubMed ID: 27014640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type IV secretion system of Brucella spp. and its effectors.
    Ke Y; Wang Y; Li W; Chen Z
    Front Cell Infect Microbiol; 2015; 5():72. PubMed ID: 26528442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The VirB System Plays a Crucial Role in
    Xiong X; Li B; Zhou Z; Gu G; Li M; Liu J; Jiao H
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brucella lipopolysaccharide acts as a virulence factor.
    Lapaque N; Moriyon I; Moreno E; Gorvel JP
    Curr Opin Microbiol; 2005 Feb; 8(1):60-6. PubMed ID: 15694858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of Brucella pathogenicity: an update.
    Sangari FJ; Agüero J
    Microbiologia; 1996 Jun; 12(2):207-18. PubMed ID: 8767705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Important biology events and pathways in Brucella infection and implications for novel antibiotic drug targets.
    Gao G; Xu J
    Crit Rev Eukaryot Gene Expr; 2013; 23(1):65-76. PubMed ID: 23557338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omp31 plays an important role on outer membrane properties and intracellular survival of Brucella melitensis in murine macrophages and HeLa cells.
    Verdiguel-Fernández L; Oropeza-Navarro R; Basurto-Alcántara FJ; Castañeda-Ramírez A; Verdugo-Rodríguez A
    Arch Microbiol; 2017 Sep; 199(7):971-978. PubMed ID: 28382472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A T4SS Effector Targets Host Cell Alpha-Enolase Contributing to
    Marchesini MI; Morrone Seijo SM; Guaimas FF; Comerci DJ
    Front Cell Infect Microbiol; 2016; 6():153. PubMed ID: 27900285
    [No Abstract]   [Full Text] [Related]  

  • 15. Epistatic Interplay between Type IV Secretion Effectors Engages the Small GTPase Rab2 in the
    Smith EP; Cotto-Rosario A; Borghesan E; Held K; Miller CN; Celli J
    mBio; 2020 Mar; 11(2):. PubMed ID: 32234817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brucella stationary-phase gene expression and virulence.
    Roop RM; Gee JM; Robertson GT; Richardson JM; Ng WL; Winkler ME
    Annu Rev Microbiol; 2003; 57():57-76. PubMed ID: 12730323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Bacterial Second Messenger Cyclic di-GMP Regulates Brucella Pathogenesis and Leads to Altered Host Immune Response.
    Khan M; Harms JS; Marim FM; Armon L; Hall CL; Liu YP; Banai M; Oliveira SC; Splitter GA; Smith JA
    Infect Immun; 2016 Dec; 84(12):3458-3470. PubMed ID: 27672085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A
    Soler-Lloréns PF; Quance CR; Lawhon SD; Stuber TP; Edwards JF; Ficht TA; Robbe-Austerman S; O'Callaghan D; Keriel A
    Front Cell Infect Microbiol; 2016; 6():116. PubMed ID: 27734009
    [No Abstract]   [Full Text] [Related]  

  • 19. Brucella virulence mechanisms and implications in novel vaccines and drugs.
    Gao G; Wang Y; Chen Z; Xu X; Xu J
    Crit Rev Eukaryot Gene Expr; 2013; 23(1):49-64. PubMed ID: 23557337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the immunopathogenesis of Brucellosis.
    Amjadi O; Rafiei A; Mardani M; Zafari P; Zarifian A
    Infect Dis (Lond); 2019 May; 51(5):321-333. PubMed ID: 30773082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.